News Release, October 8, 2018: The Australian Government will invest $1 million to improve recovery and rehabilitation and help stroke survivors back to work. The Government package includes $750,000 specifically designated for funding a clinical trial of the innovative Perispinal Etanercept Stroke Treatment in Australia. “The project will enable more Australians of working age who have had a stroke to access new innovative and cutting edge treatment options to aid their recovery.”
Perispinal etanercept for treatment of chronic post-stroke neurological dysfunction is a treatment method invented and developed by Edward Tobinick M.D., Medical Director and Founder of the Institute of Neurological Recovery.
More at this link: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-hunt134.htm
The Hon Greg Hunt MP, Minister for Health, Australia
Family from Melbourne, Australia. Treatment at the Institute of Neurological Recovery in Boca Raton on October 23-30, 2017; almost 3 years after stroke. For further information, please visit strokebreakthrough.com
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.